Hospital-Acquired Infections Market Size, Share, Growth Analysis, By Type (Equipment, Consumables), By Treatment (Antibacterial, Antiviral), By Infection Type, By End User, By Region - Industry Forecast 2025-2032

Global Hospital-Acquired Infections Market size was valued at USD 30.4 billion in 2023 and is poised to grow from USD 30.86 billion in 2024 to USD 34.76 billion by 2032, growing at a CAGR of 1.5% during the forecast period (2025-2032).

The infection control market is witnessing robust growth driven by heightened awareness of Hospital Acquired Infections (HAIs), the urgent need to combat cross infections, and the rising prevalence of infectious diseases within healthcare facilities. Key products such as sterilization equipment, cleaning and disinfection agents, protective barriers, and endoscope reprocessing tools play crucial roles in minimizing hospital-acquired infections. Additionally, supportive government initiatives advocating for improved infection control measures further bolster this sector. The adoption of comprehensive infection prevention guidelines at hospital, regional, and national levels, along with the growing integration of monitoring technologies, are significant factors fueling market expansion. As awareness and compliance grow, the demand for effective infection control products and services continues to rise, making this a dynamic and vital market space.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hospital-Acquired Infections market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hospital-Acquired Infections Market Segmental Analysis

Global Hospital-Acquired Infections Market is segmented by Type, Treatment, Infection Type, End User and region. Based on Type, the market is segmented into Equipment, Consumables and Services. Based on Treatment, the market is segmented into Antibacterial, Antiviral, Antifungal and Others. Based on Infection Type, the market is segmented into Bloodstream Infections, Ventilator-Associated Pneumonia (VAP), Urinary Tract Infection, Surgical-Site Infection, Gastrointestinal Infections and Others. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hospital-Acquired Infections Market

The Global Hospital-Acquired Infections market is poised for growth driven by the rising number of surgical procedures performed globally. According to the World Health Organization, approximately 235 million major surgeries are carried out annually, a trend fueled by the increasing prevalence of obesity, lifestyle-related diseases, an aging population, and a surge in spine and sports injuries. As more surgeries take place, the demand for surgical tools and medical devices escalates. The recognized advantages of sterilized equipment, coupled with heightened awareness of their importance in healthcare environments, are expected to significantly boost the demand for services addressing hospital-acquired infections.

Restraints in the Global Hospital-Acquired Infections Market

The growth of the Global Hospital-Acquired Infections market is hindered by apprehensions surrounding the safety of reprocessed medical instruments. While reusing devices like surgical forceps, endoscopes, and stethoscopes can significantly reduce costs and environmental waste for healthcare providers, doubts persist regarding the efficacy and cleanliness of these reprocessed items. Improper cleaning and sterilization processes might leave behind blood, tissue, and other biological residue, elevating the risk of surgical-site infections (SSIs) and hospital-acquired infections (HAIs). Furthermore, any residual materials, such as chemical disinfectants, could lead to tissue irritation. This uncertainty is resulting in limited acceptance of device reprocessing among hospital administrators and clinicians.

Market Trends of the Global Hospital-Acquired Infections Market

The Global Hospital-Acquired Infections (HAIs) market is experiencing significant growth, propelled by a surge in chronic diseases like diabetes, cardiovascular disorders, and gastrointestinal conditions. With environmental and lifestyle factors contributing to rising disease prevalence-projected to escalate from 537 million diabetics in 2021 to approximately 783 million by 2045-there will be an uptick in surgical procedures, consequently elevating the risk of HAIs. Increased awareness and need for stringent sterilization and disinfection protocols will further drive demand for infection control devices. As such, the market is poised for robust expansion, addressing both the rise in surgical interventions and the necessity for enhanced infection prevention measures.